Evaluation of biopsy pathology in diagnosis of ulcerative colitis

World Chinese Journal of Digestology

Volumn 9, Issue 11, 2001, Pages 1269-1273

  Peng, Z S ^a   Hu, P J ^a   Lin, H L ^a   Cui, Y ^a   Chen, W ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biopsy methods; Colitis, ulcerative diagnosis; Colitis, ulcerative pathology

Indexed keywords

EOSIN; HEMATOXYLIN; MUCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENTERITIS; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE CRYPT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NEUTROPHIL CHEMOTAXIS; PLASMACYTOSIS; SCORING SYSTEM; STOMACH BIOPSY; TISSUE SECTION; ULCERATIVE COLITIS;

EID: 0035198743     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. An analysis on the endoscopic data of ulcerative colitis 128 cases
2. Features of ulcerative colitis in China: An analysis 10218 cases
3. Recent advances in research of ulcerative colitis
4. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?
5. The importance of diagnostic accuracy in colonic inflammatory bowel disease
6. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea
7. Surveillance issues in inflammatory bowel disease: Ulcerative colitis
8. Inflammatory intestinal diseases: Research diagnosis and treatment
9. Colonoscopy for inflammatory bowel disease
10. Crohn's disease, ulcerative colitis or indeterminate colitis - How important is it to differentiate?
11. Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea
12. The use of H magnetic resonance spectroscopy in inflammatory bowel diseases: Distinguishing ulcerative colitis from Crohn's disease
13. Epidemiology and the natural course of inflammatory bowel disease
14. Medical therapy for inflammatory bowel disease
15. Microaggaregate of immunostained macrophages in noninflammed gastroduodenal mucosa: A new useful histological marker for differentiating Crohn's colitis from colitis
16. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study
17. Chrohn's disease in Japan: Diagnostic criteria and epidemiology
18. Update in medical therapy in inflammatory bowel disease: A clinician's view
19. Therapy of inflammation bowel disease
20. Biopsy diagnosis of colitis: Possibilities and pitfalls
21. Diagnostic approach to IBD
22. The differential diagnosis of Crohn's disease and ulcerative colitis
23. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time
24. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The british society of gastroenterology initiative
25. Medical audit of rectal biopsy diagnosis of inflammatory bowel disease
26. Quantitation in inflammatory bowel disease using computerized interactive image analysis
27. What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens
28. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: Diagnostic implications
29. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease
30. Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: Achievable standards for the diagnosis of inflammatory bowel disease
31. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis
32. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: Measurement of validity
33. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
34. The effectiveness and limitation of colonoscopic diagnosis on ulcerative colitis - With an analysis of 116 cases
35. Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis
36. Fulminant colitis in inflammatory bowel disease: Detailed pathologic and clinical analysis
37. Histological, histochemical and ultrastructural study of ulcerative colitis
38. Endoscopic biopsy diagnosis of inflammatory bowel disease
39. Mucosal biopsy diagnosis of colitis: Acute self-limited colitis and idiopathic inflammatory bowel disease
40. Reliability of rectal biopsy in distinguishing between chronic inflammatory bowel disease and acute self-limiting colitis
41. Ulcerative colitis: Patterns of involvement in colorectal biopsies and changes with time
42. Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis
43. Clinical, biological, and histological parameters as predictors of relapse in ulcerative colitis
44. Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis
45. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis
46. Infliximab for refractory ulcerative colitis
47. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: An open-label study
48. Prediction of short-term outcome for patients with active ulcerative colitis
49. Ulcerative colitis
50. The pathological diagnosis and differential diagnosis of inflammatory bowel disease